pubmed-article:954102 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:954102 | lifeskim:mentions | umls-concept:C0079382 | lld:lifeskim |
pubmed-article:954102 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:954102 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
pubmed-article:954102 | lifeskim:mentions | umls-concept:C0035696 | lld:lifeskim |
pubmed-article:954102 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:954102 | lifeskim:mentions | umls-concept:C0205360 | lld:lifeskim |
pubmed-article:954102 | lifeskim:mentions | umls-concept:C0017645 | lld:lifeskim |
pubmed-article:954102 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:954102 | pubmed:dateCreated | 1976-10-20 | lld:pubmed |
pubmed-article:954102 | pubmed:abstractText | Biosynthesis and stability of the mRNA population in DMSO-induced Friend erythroleukemic cells were studied after labeling the RNA with 3H-uridine and then chasing it with nonlabeled uridine. Globin RNA metabolism was studied by hybridization to excess complementary DNA convalently coupled to oligo(dT)-cellulose. After a labeling period of 120 min, 2-4% of the poly(A)-containing labeled RNA was in globin RNA; it decayed with a half-life of 16-17 hr. The rest of the poly(A)-containing RNA was composed to two kinetic populations: 85-90% decayed with a half-life of about 3 hr, while 10% decayed with a half-life of about 37 hr. The portion of globin RNA in labeled poly(A)-containing RNA behaved in an unexpected fashion during the chase period. During the initial chase period, the percentage of globin RNA increased rapidly, reaching a maximum of about 15% at 20 hr, but it subsequently declined gradually. Based on these findings, a model was built that describes the changes in the proportion of globin mRNA in poly(A)-containing RNA during continuous synthesis and after chase of the labeled RNA. It appears that if the parameters described remain constant during the maturation of erythroblasts, then this model would not account for the almost exclusive presence of globin RNA in the reticulocyte. By far the most effective way to achieve this high level of globin RNA is the destabilization of the mRNA population which is more stable than globin RNA, and not the stabilization of globin RNA itself. | lld:pubmed |
pubmed-article:954102 | pubmed:language | eng | lld:pubmed |
pubmed-article:954102 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:954102 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:954102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:954102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:954102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:954102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:954102 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:954102 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:954102 | pubmed:month | Aug | lld:pubmed |
pubmed-article:954102 | pubmed:issn | 0092-8674 | lld:pubmed |
pubmed-article:954102 | pubmed:author | pubmed-author:LevySS | lld:pubmed |
pubmed-article:954102 | pubmed:author | pubmed-author:AvivHH | lld:pubmed |
pubmed-article:954102 | pubmed:author | pubmed-author:VolochZZ | lld:pubmed |
pubmed-article:954102 | pubmed:author | pubmed-author:BastosRR | lld:pubmed |
pubmed-article:954102 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:954102 | pubmed:volume | 8 | lld:pubmed |
pubmed-article:954102 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:954102 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:954102 | pubmed:pagination | 495-503 | lld:pubmed |
pubmed-article:954102 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:954102 | pubmed:meshHeading | pubmed-meshheading:954102-E... | lld:pubmed |
pubmed-article:954102 | pubmed:meshHeading | pubmed-meshheading:954102-G... | lld:pubmed |
pubmed-article:954102 | pubmed:meshHeading | pubmed-meshheading:954102-R... | lld:pubmed |
pubmed-article:954102 | pubmed:meshHeading | pubmed-meshheading:954102-R... | lld:pubmed |
pubmed-article:954102 | pubmed:meshHeading | pubmed-meshheading:954102-M... | lld:pubmed |
pubmed-article:954102 | pubmed:meshHeading | pubmed-meshheading:954102-D... | lld:pubmed |
pubmed-article:954102 | pubmed:meshHeading | pubmed-meshheading:954102-C... | lld:pubmed |
pubmed-article:954102 | pubmed:meshHeading | pubmed-meshheading:954102-H... | lld:pubmed |
pubmed-article:954102 | pubmed:meshHeading | pubmed-meshheading:954102-P... | lld:pubmed |
pubmed-article:954102 | pubmed:year | 1976 | lld:pubmed |
pubmed-article:954102 | pubmed:articleTitle | Biosynthesis and stability of globin mRNA in cultured erythroleukemic Friend cells. | lld:pubmed |
pubmed-article:954102 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:954102 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:954102 | lld:pubmed |